Skip to search formSkip to main contentSkip to account menu

Ziagen

National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

abacavirabacavir sulfate
abacavir 20 MG/ML Oral Solution [Ziagen]abacavir Oral Tablet [Ziagen]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients
Background Abacavir is a widely-used nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus… 
2014
2014
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
Abacavir is a nucleoside reverse transcriptase inhibitor indicated for human immunodeficiency virus (HIV) infection. In Japan… 
2008
2008
A brief history of the development of ziagen
2003
2003
Capillary electrophoresis‐ion trap mass spectrometry analysis of Ziagen® and its phosphorylated metabolites
A capillary electrophoresis‐ion trap mass spectrometry method with a time‐segment program was developed to simultaneously analyze… 
2002
2002
FDA notifications. Product tampering labels Ziagen as Combivir.
Highly Cited
2001
Highly Cited
2001
Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography.
Highly Cited
2001
Highly Cited
2001
Simultaneous determination of Ziagen and its phosphorylated metabolites by ion-pairing high-performance liquid chromatography-tandem mass spectrometry.
1999
1999
Abacavir sulfate (Ziagen).
  • P. Simmons
  • Research initiative, treatment action : RITA
  • 1999
  • Corpus ID: 23161390
Abacavir sulfate (Ziagen) received accelerated approval for treatment of HIV infection from the Food and Drug Administration… 
1999
1999
Ziagen (abacavir) approved: caution essential.
The Food and Drug Administration (FDA) announced accelerated approval of Glaxo-Wellcome's abacavir (Ziagen, 1592) in… 
1998
1998
1592 (abacavir, or new name Ziagen) more widely available March 23.
Glaxo Wellcome has expanded its access program for its experimental drug abacavir (Ziagen, formerly known as 1592). The program… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)